ESCRS - Lymphatic drainage a newly discovered route of aqueous outflow ;
ESCRS - Lymphatic drainage a newly discovered route of aqueous outflow ;

Lymphatic drainage a newly discovered route of aqueous outflow

Research is providing new insight into the outflow patterns aqueous in eyes with glaucoma that may in turn allow greater individualisation of treatment

Lymphatic drainage a newly discovered route of aqueous outflow
Roibeard O’hEineachain
Roibeard O’hEineachain
Published: Sunday, May 20, 2018
Research is providing new insight into the outflow patterns aqueous in eyes with glaucoma that may in turn allow greater individualisation of treatment, said Stefano Gandolfi MD at the 13th European Glaucoma Society Congress in Florence Italy. “The interest in monitoring the outflow of the aqueous humour from the eye actually has recently become extremely compelling both in terms of research and new medications that are expected to work directly on the physiological outflow mechanisms of the eye,” said Dr Gandolfi, University of Bologna, Italy. Dr Gandolfi noted that in addition to the conventional trabecular-canalicular outflow and uveoscleral outflow,  new research from Neeru Gupta’s  group in Canada suggests that lymphatic vessels in the eye may also provide a means of aqueous drainage from the anterior chamber that may also be modulated pharmacologically. Recent research also suggests that eye drops consisting of a combination of indocyanine green and liposomes can allow visualisation of Schlemm’s canal and the collector channels, as well as the lymphatic outflow patterns of the aqueous in the individual eye. “That may allow us to make better patient selection. On top of that having it will help to measure the lymphatic areas that are being shown to be relevant in determining the total capability of the eye to drain the aqueous humour from the anterior chamber straight into the conventional pathways,” Dr Gandolfi said.          
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;